"For more than 50 years, we have built this practice around helping people see their best. That means providing the best specialists for each part of the eye and every type of vision problem. When you see a Sabates Eye Centers eye doctor, your care and treatment come from someone at the top of their field, along with technicians and staff who deliver true five-star service. All of us – ophthalmologists, optometrists, opticians and technicians – are under “one roof” making us the largest subspecialty eye care practice in the region. Specialties offered at this location: advanced cataract treatment, cornea, cosmetics, glaucoma, LASIK, reconstructive, retina, oncology and neuro-ophthalmology. Sabates- The most trusted name in eye care."

During the past decade, Sabates Eye Centers conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sabates Eye Centers" #1 sponsor was "Allergan" with 3 trials, followed by "Shire" with 2 trials sponsored, "ThromboGenics" with 2 trials sponsored, "Unity Biotechnology, Inc." with 2 trials sponsored and "Alimera Sciences" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sabates Eye Centers" #1 collaborator was "Milton S. Hershey Medical Center" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator, "Stada Arzneimittel AG" with 1 trials as a collaborator and "University of Wisconsin, Madison" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Sabates Eye Centers" are "Macular Degeneration" (4 trials), "Diabetic Macular Edema (DME)" (2 trials), "Geographic Atrophy" (2 trials), "Adenoviral Conjunctivitis" (1 trials) and "Age-Related Maculopathy" (1 trials). Many other conditions were trialed in "Sabates Eye Centers" in a lesser frequency.

Most popular intervention types in "Sabates Eye Centers" are "Drug" (13 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ranibizumab" (2 trials), "SHP640" (2 trials), "Sham Procedure" (2 trials) and "ABP 938" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sabates Eye Centers" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Sabates Eye Centers". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Sabates Eye Centers, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sabates Eye Centers, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".